Anebulo Pharmaceuticals's total assets for Q1 2026 were $10.70M, a decrease of -11.89% from the previous quarter. ANEB total liabilities were $963.82K for the fiscal quarter, a 97.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.